?

Serafini-Lamanna Tony

Executive VP-Diagnostics
Meridian Bioscience, Inc.
US, Cincinnati [HQ]
CIK 1812602

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
18,093
Price per Share :
$33.97
Equivalence :
$614,619.21

Transaction History

  • 18,093 Shares After Transaction
    Value : $n/a
    $0.0
    11/15/21
  • Footnotes:
    #1 Restricted share units granted pursuant to 2012 Stock Incentive Plan rescinded by the Issuer.
    #2 Restricted share units granted pursuant to 2021 Omnibus Award Plan scheduled to vest as follows: (i) 1,200 on September 16, 2022; (ii) 12,320 on November 15, 2022; and (iii) 10,823 on November 15, 2023.
  • 42,436 Shares After Transaction
    Value : $n/a
    $0.0
    11/15/21
  • 43,338 Shares After Transaction
    Value : $n/a
    $0.0
    01/31/23
  • 0.0 Shares After Transaction
    Value : $n/a
    $0.0
    01/31/23
  • 39,847 Shares After Transaction
    Value : $1,280,682.58
    $11,473.98
    09/16/22

Get PRO Today.

PRO unlocks 3 more insider transactions made by Serafini-Lamanna Tony